Evidence map›Paper›PMID 29959696›Full record

Observational studyHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2018

Prevalence and Comorbidities of Resistant Hypertension: A Collaborative Population-Based Observational Study.

Simone Romano, Chiara Idolazzi, Cristiano Fava, Luigi Fondrieschi, Mario Celebrano, Pietro Delva, Lorella Branz, Angela Donato, Andrea Dalbeni, Pietro Minuz

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Resistant Hypertension and Related Outcomes in a Cohort of Patients with Cardiorenal Multimorbidity Hospitalized in an Internal Medicine Ward.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. The Burden of Resistant Hypertension Across the World.Current hypertension reports · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Simone RomanoSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Chiara IdolazziSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Cristiano FavaSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Luigi FondrieschiSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Mario CelebranoSIMG, Italian Society of Primary Care Physicians, Florence, Italy.
Pietro DelvaSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Lorella BranzSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Angela DonatoSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Andrea DalbeniSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy.
Pietro MinuzSection of General Medicine and Hypertension, Department of Medicine, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro 10, 37134, Verona, Italy. pietro.minuz@univr.it.
University of Verona · ITSocietà Italiana di Medicina Generale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResistant hypertension, is a clinical condition that may confer high cardiovascular risk. Aim of the observational study was to evaluate the prevalence of resistant hypertension, and the association with cardiovascular risk factors or diseases in the Verona urban area. DESIGN AND

methodsEleven family doctors retrieved anonymised data concerning blood pressure, diagnosis of hypertension and treatments from a population of 17,502 adult subjects. The prevalence of resistant hypertension was estimated considering patients who had been consecutively treated with at least four antihypertensive medications, regardless of blood pressure values. Further search concerning the clinical characteristics associated with resistant hypertension was performed in a random subsample of 55 patients.

resultsThe prevalence of hypertension was 21.9%, that of resistant hypertension was 2.1%, approximately 10% of the whole hypertensive population. High prevalence of diabetes mellitus (53%) and hyperlipidemia (83%) was found in association with resistant hypertension. As for end organ damage, high prevalence of carotid artery stenosis (45%), ischemic heart disease (43%) and left ventricular hypertrophy (40%) was observed in patients with resistant hypertension. Blood pressure was higher than 140/90 mmHg in 58% of patients in spite of treatment with four or more different antihypertensive drugs. The average age, systolic and pulse pressure were significantly higher in the subgroup of patients with resistant hypertension.

conclusionsPatients with resistant hypertension are characterised by a higher systolic and pulse pressure and a very high attributable cardiovascular risk, due to high prevalence of cardiovascular risk factors and overt organ damage and cardiovascular disease.

Indexed as

Drug ResistanceAgedAged, 80 and overAntihypertensive AgentsBlood PressureComorbidityFemaleHumansHypertensionItalyMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsUrban HealthAntihypertensive AgentsBlood pressureComorbiditiesEpidemiologyHypertensionPrevalenceResistant hypertension

Identifiers

PMID29959696
OpenAlexW2810838346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.